Akili to merge with Virtual Therapeutics in $34M deal
Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness company Virtual Therapeutics in a deal reportedly worth $34 million. Under the agreement, which is slated to close in the third quarter of 2024, Akili shareholders will receive $0.4340…